All Publications — CAMS Oxford Institute

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19

Liu G. et al, (2025), Nature Communications, 16

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response

Drennan PG. et al, (2025), The Lancet Microbe, 6, 101045 - 101045

T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination

Chen J-L. et al, (2025), Nature Communications, 16

Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity

Hamid MHBA. et al, (2024), Nature Immunology, 25, 834 - 846

Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2

Antoun E. et al, (2023), Nature Immunology, 24, 1594 - 1596

Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy

Chen Q. et al, (2023), Cellular & Molecular Immunology, 20, 1300 - 1312

HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation

Yang H. et al, (2023), Science Immunology, 8

Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination

Yin Z. et al, (2023), Cell Reports, 42, 112470 - 112470

Engineering Immunosuppressive Drug Resistant Armored (IDRA) SARS-CoV-2 T cells for cell therapy

Bertoletti A. et al, (2023)

T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles

Céspedes PF. et al, (2022), Nature Communications, 13

Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control

Dong T. et al, (2022)

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345

Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease

Zhao Y. et al, (2020), JCI Insight, 5

Human cancer germline antigen-specific cytotoxic T cell—what can we learn from patient

Abd Hamid M. et al, (2020), Cellular & Molecular Immunology, 17, 684 - 692

Load More